Viewing Study NCT05711394


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2025-12-27 @ 3:54 AM
Study NCT ID: NCT05711394
Status: RECRUITING
Last Update Posted: 2025-07-08
First Post: 2023-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module